Drug intelligence / Profile preview

Tetatox

Development stage
Approved
Lead developer
BulBio-NCIPD
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Tetatox is a monovalent tetanus vaccine developed and manufactured by the Bulgarian state-owned biomedical company BulBio (BB-NCIPD EAD). The vaccine consists of purified tetanus toxoid, which is typically adsorbed onto an aluminum adjuvant (such as aluminum hydroxide or aluminum phosphate) to enhance the immune response. Tetatox works by inducing the production of specific neutralizing antibodies against the tetanus toxin produced by the bacterium *Clostridium tetani*. It is indicated for the active immunization against tetanus in children and adults, and is also used for post-exposure prophylaxis in wound management to prevent the development of clinical tetanus.

Brand names
Tetatox
Other names
tetanus toxoidtetanus vaccinetetanus toxoid (adsorbed)

Beyond the preview

Go deeper on Tetatox.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetatox.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call